Tejaswini Kulkarni

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Citrullinated vimentin mediates development and progression of lung fibrosis

Fu Jun Li, Ranu Surolia, Huashi Li et al. · Science Translational Medicine · 2021 · 109 citations · Full text

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis

Camille M. Moore, Rachel Z. Blumhagen, Ivana V. Yang et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 105 citations · Full text

Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis

Fu Jun Li, Ranu Surolia, Huashi Li et al. · The Journal of Immunology · 2017 · 92 citations · Full text

Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status

Tejaswini Kulkarni, Simon Gollins, A. Maw et al. · Colorectal Disease · 2008 · 83 citations